GC

Grant Castor

Senior Vice President Commercial Strategy & Operations at Sentynl Therapeutics, Inc.

Grant Castor leads global commercial strategy, finance, and operations for the portfolio of therapeutics in rare and ultra-rare diseases at Sentynl Therapeutics, Inc. Prior to this, Grant held various roles in commercial operations and marketing at Amedra Pharmaceuticals LLC, Hemaclear, OHK Medical Devices, Allied Orthopedic Associates - Zimmer Spine, and Prescient Medical, Inc. Grant holds a B. Sc. in International Business from Johnson & Wales University.

Location

Fannett, United States

Links

Previous companies


Org chart


Teams


Offices


Sentynl Therapeutics, Inc.

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.